Immunogenicity and Safety of the M72/AS01E Candidate Vaccine Against Tuberculosis: A Meta-Analysis
Conclusion: The M72/AS01E vaccine against TB is safe and effective. Although the vaccine is associated with a mild adverse reaction, it is promising for the prevention of TB in healthy adults.
Keywords: vaccine, tuberculosis, M72/AS01E, immunogenicity, safety
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Clinical Trials | Databases & Libraries | Headache | Migraine | Pain | Study | Tuberculosis | Tuberculosis (BCG) Vaccine | Vaccines